Azzad Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Sell
915
-101
-10% -$46.6K 0.04% 308
2026
Q1
$488K Buy
1,016
+12
+1% +$6.14K 0.05% 289
2025
Q4
$564K Buy
+1,004
New +$570K 0.06% 283
2025
Q3
Sell
-846
Closed -$266K 342
2025
Q2
$266K Buy
846
+35
+4% +$10.5K 0.03% 296
2025
Q1
$247K Buy
811
+21
+3% +$7.06K 0.03% 292
2024
Q4
$263K Buy
790
+4
+0.5% +$1.36K 0.05% 165
2024
Q3
$262K Buy
+786
New +$299K 0.03% 292
2023
Q3
Sell
-2,082
Closed -$500K 317
2023
Q2
$500K Buy
2,082
+320
+18% +$66.5K 0.07% 273
2023
Q1
$331K Sell
1,762
-2,246
-56% -$465K 0.05% 292
2022
Q4
$851K Sell
4,008
-6,160
-61% -$1.23M 0.13% 209
2022
Q3
$1.2M Buy
10,168
+914
+10% +$146K 0.12% 250
2022
Q2
$1.04M Buy
9,254
+7,105
+331% +$1.03M 0.1% 267
2022
Q1
$352K Sell
2,149
-505
-19% -$83.3K 0.05% 293
2021
Q4
$578K Sell
2,654
-4,506
-63% -$944K 0.08% 282
2021
Q3
$1.36M Buy
7,160
+102
+1% +$18.6K 0.2% 186
2021
Q2
$1.25M Sell
7,058
-951
-12% -$164K 0.19% 201
2021
Q1
$1.31M Buy
8,009
+969
+14% +$148K 0.22% 185
2020
Q4
$980K Buy
7,040
+108
+2% +$13.6K 0.18% 191
2020
Q3
$775K Buy
6,932
+798
+13% +$92.3K 0.16% 196
2020
Q2
$571K Buy
6,134
+204
+3% +$17.4K 0.13% 222
2020
Q1
$435K Sell
5,930
-5,908
-50% -$513K 0.13% 238
2019
Q4
$1.05M Buy
11,838
+487
+4% +$37.7K 0.12% 236
2019
Q3
$1.01M Buy
+11,351
New +$858K 0.13% 241

Other funds holding MEDP

Azzad Asset Management's MEDP Position: Q2 2026 in Review

Azzad Asset Management reduced its Medpace (MEDP) stake by 9.9% in Q2 2026, selling an estimated $46.6K and leaving 915 shares worth $485K. The position accounts for 0.04% of the portfolio, ranked #308.

Azzad Asset Management first reported a position in MEDP in Q3 2019 and has held it in 23 quarters since. The position peaked at $1.36M in Q3 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Azzad Asset Management held 915 shares of Medpace worth $485K as of Q2 2026.
  • Azzad Asset Management sold 101 Medpace shares in Q2 2026, an estimated $46.6K.
  • Medpace made up 0.04% of Azzad Asset Management's portfolio in Q2 2026, its #308 holding.
  • Azzad Asset Management first reported a position in Medpace in Q3 2019 and has held it in 23 quarters since.
  • Azzad Asset Management's Medpace position peaked at $1.36M in Q3 2021.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.